[ad_1]
The drug remdesivir, used to treat coronavirus disease in US President Donald Trump, could cause side effects in COVID-19 patients in Europe who subsequently had kidney problems.
Deutsche Welle writes about it.
The European Medicines Agency (EMA) has started testing the drug Remdesivir, which is used to treat COVID-19, due to information that some patients who took the drug subsequently suffered from kidney problems. EMA experts are investigating whether this could be a consequence of remdesivir use or a consequence of coronavirus infection.
The EMA allows remdesivir exclusively for the treatment of adult COVID-19 patients 12 years of age and older.
Current estimates of the efficacy of remdesivir, which is a drug for treating Ebola, are based on research from the US Institute of Allergy and Infectious Diseases (NIAID), according to which remdesivir can significantly speed up the treatment of COVID-19 patients.
Remdesivir was developed by the American company Gilead; In the United States and Japan, the drug has already received special permission for the treatment of the COVID-19 disease caused by the coronavirus.
As reported by “Apostrophe”, the coronavirus does not always present typical symptoms in the form of fever, shortness of breath and cough, there are cases in which it affects the nervous system.
[ad_2]
